To semi-quantitatively evaluate the GRPEL2 protein expression in human gliomas, we applied microarrayed tissue slides containing various WHO-grade gliomas for immuno-histochemical (IHC) staining. This evidence concerns the gene GRPEL2 and central nervous system cancer.